Applied Therapeutics Inc (APLT)
$4.31
Market is closed - opens 7 PM, 25 Apr 2024
Performance
- $4.17$4.56$4.31
3.25%
Downside
Day's Volatility :8.45%
Upside
5.38%
- $1.18$9.39$4.31
72.62%
Downside
52 Weeks Volatility :87.43%
Upside
54.1%
Returns
| Period | Applied Therapeutics Inc | Sector (Health Care) | Index (Russel 2000) |
|---|---|---|---|
3 Months | 47.6% | 1.7% | 0.0% |
6 Months | 55.04% | 11.3% | 0.0% |
1 Year | 220.71% | 5.4% | 1.3% |
3 Years | -79.11% | 13.9% | -22.1% |
Highlights
Market Capitalization | 509.5M |
Book Value | - $0.2 |
Earnings Per Share (EPS) | -1.42 |
Wall Street Target Price | 11.6 |
Profit Margin | 0.0% |
Operating Margin TTM | 3149.63% |
Return On Assets TTM | -86.56% |
Return On Equity TTM | -682.16% |
Revenue TTM | 10.0M |
Revenue Per Share TTM | 0.12 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
EBITDA | -64.5M |
Diluted Eps TTM | -1.42 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.72 |
EPS Estimate Next Year | -0.39 |
EPS Estimate Current Quarter | -0.23 |
EPS Estimate Next Quarter | -0.18 |
Analyst Recommendation
Buy
88%Buy
11%Hold
0
0%Sell
Based on 9 Wall street analysts offering stock ratings for Applied Therapeutics Inc(by analysts ranked 0 to 5 stars)
Based on 9 analyst
- Current
- 1M Ago
- 3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
00
00
00
Analyst Forecast
What analysts predicted
Upside of 169.14%
Current $4.31
Target $11.60
Technicals Summary
Sell
Neutral
Buy
Applied Therapeutics Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Applied Therapeutics Inc | -36.15% | 55.04% | 220.71% | -79.11% | -79.11% |
 Moderna, Inc. | -1.39% | 41.81% | -19.31% | -38.71% | 322.88% |
 Regeneron Pharmaceuticals, Inc. | -5.68% | 13.74% | 14.81% | 80.88% | 159.02% |
 Novo Nordisk A/s | -2.24% | 29.49% | 49.67% | 240.51% | 421.0% |
 Vertex Pharmaceuticals Incorporated | -3.67% | 10.39% | 20.74% | 84.71% | 129.52% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Applied Therapeutics Inc | NA | NA | NA | -0.72 | -6.82 | -0.87 | NA | -0.2 |
Moderna, Inc. | 24.73 | NA | 0.0 | -6.77 | -0.29 | -0.12 | NA | 36.27 |
Regeneron Pharmaceuticals, Inc. | 26.13 | 26.13 | 1.46 | 45.02 | 0.16 | 0.08 | NA | 242.47 |
Novo Nordisk A/s | 48.36 | 48.36 | 2.4 | 3.34 | 0.88 | 0.23 | 0.01 | 23.9 |
Vertex Pharmaceuticals Incorporated | 29.17 | 29.17 | 0.53 | 16.75 | 0.23 | 0.13 | NA | 68.22 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Applied Therapeutics Inc | Buy | $509.5M | -79.11% | NA | 0.0% |
Moderna, Inc. | Buy | $41.3B | 322.88% | 24.73 | -68.84% |
Regeneron Pharmaceuticals, Inc. | Buy | $99.6B | 159.02% | 26.13 | 30.14% |
Novo Nordisk A/s | Buy | $573.9B | 421.0% | 48.36 | 36.03% |
Vertex Pharmaceuticals Incorporated | Buy | $104.7B | 129.52% | 29.17 | 36.68% |
Institutional Holdings
Franklin Resources Inc
6.63%VR Adviser, LLC
5.34%Knoll Capital Management LP
5.17%Propel Bio Management LLC
5.08%Alyeska Investment Group, L.P.
3.99%Vestal Point Capital LP
3.92%
Corporate Announcements
Applied Therapeutics Inc Earnings
Applied Therapeutics Inc’s price-to-earnings ratio stands at None
Read More
Company Information
applied therapeutics, inc. is a hospital and health care company located in 3104 cherry palm dr, tampa, fl, united states.
Organization | Applied Therapeutics Inc |
Employees | 25 |
CEO | Dr. Shoshana Shendelman Ph.D. |
Industry | Biotechnology |
